{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:23:42Z","timestamp":1790267022057,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) with axillary lymph node metastasis (ALNM) represents a high-risk population with substantially worse prognosis compared to other breast cancer subtypes. Despite the critical clinical importance of accurate prognostic assessment in this population, no validated risk prediction model specifically tailored for TNBC patients with ALNM currently exists. Machine learning approaches offer the potential to integrate multiple clinical and pathological factors for improved risk stratification, yet their application in this specific context remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analyzed 19,289 TNBC patients with ALNM from the Surveillance, Epidemiology, and End Results (SEER) database (2015-2020). Patients were randomly allocated to training (n=13,502, 70%) and validation (n=5,787, 30%) cohorts. Independent prognostic factors were identified through univariable and multivariable Cox regression analysis. Five machine learning-based survival models were developed and compared: Cox Proportional Hazards (CoxPH), Random Survival Forest (RSF), Extremely Randomized Survival Trees (ERST), Gradient Boosting Survival Analysis (GBSA), and Survival Tree (ST). Model performance was evaluated using concordance index (C-index), time-dependent area under the curve (AUC), Brier scores, calibration curves, and decision curve analysis. SHapley Additive exPlanations (SHAP) analysis was employed to enhance model interpretability and identify key prognostic drivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariable Cox regression identified 13 independent prognostic factors encompassing demographic characteristics (age, race, marital status, household income), tumor pathological features (histology type, T stage, N stage, M stage, tumor grade, tumor size), and treatment modalities (surgery, radiotherapy, chemotherapy). The four ensemble\/regression models (ERST, RSF, GBSA, CoxPH) demonstrated comparable C-indices (0.7494, 0.7489, 0.7483, and 0.7455, respectively) and substantially outperformed ST (0.6959); ERST was selected for downstream SHAP interpretation given its marginally highest C-index. Time-dependent AUC values for 1-, 3-, and 5-year survival predictions were 0.889, 0.773, and 0.740, respectively, with corresponding Brier scores of 0.014, 0.067, and 0.151, indicating excellent discriminatory ability and calibration. Decision curve analysis confirmed favorable clinical utility across a wide range of threshold probabilities. SHAP analysis revealed tumor grade, N stage, and radiotherapy as the three most influential prognostic factors, with high tumor grade, advanced nodal stage, and absence of radiotherapy consistently associated with increased mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed and internally validated the first machine learning-based prognostic model specifically for TNBC patients with ALNM, integrating 13 clinicopathological variables. The ERST model demonstrated robust discriminatory performance, excellent calibration, and favorable clinical utility. SHAP-based interpretability analysis provided transparent insights into key prognostic drivers, facilitating individualized risk assessment and clinical translation. This tool addresses a critical gap in precision oncology for this high-risk population and has the potential to inform treatment decisions, optimize surveillance strategies, and improve prognostic counseling. Future prospective validation in independent cohorts and integration of molecular biomarkers represent important next steps toward clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1874031","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:23:50Z","timestamp":1783657430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Machine learning-based prognostic model for triple-negative breast cancer with axillary lymph node metastasis"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruyi","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi People\u2019s Hospital, Wuxi Medical Center, Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi People\u2019s Hospital, Wuxi Medical Center, Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xidong","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi People\u2019s Hospital, Wuxi Medical Center, Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi People\u2019s Hospital, Wuxi Medical Center, Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi People\u2019s Hospital, Wuxi Medical Center, Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res BCR"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19107","DOI":"10.1038\/s41598-019-55710-w","article-title":"Molecular stratification within triple-negative breast cancer subtypes","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102855","article-title":"Triple negative breast cancer: a thorough review of biomarkers","volume":"145","author":"da Silva","year":"2020","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/diseases11030118","article-title":"Tumor characteristics associated with axillary nodal positivity in triple negative breast cancer","volume":"11","author":"Chintapally","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41598-021-04316-2","article-title":"Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer","volume":"12","author":"Hsu","year":"2022","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04859-z","article-title":"Radiomics nomogram based on digital breast tomosynthesis: preoperative evaluation of axillary lymph node metastasis in breast carcinoma","volume":"149","author":"Xu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20191019","article-title":"Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer","volume":"93","author":"Tan","year":"2020","journal-title":"Br J Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.kint.2020.07.035","article-title":"A practical guide to multiple imputation of missing data in nephrology","volume":"99","author":"Blazek","year":"2021","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.11.010","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341x.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2021.0223","article-title":"Review of statistical methods for evaluating the performance of survival or other time-to-event prediction models (from conventional to deep learning approaches)","volume":"22","author":"Park","year":"2021","journal-title":"Korean J Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01101","article-title":"Interpretation of compound activity predictions from complex machine learning models using local approximations and Shapley values","volume":"63","author":"Rodr\u00edguez-P\u00e9rez","year":"2020","journal-title":"J Med Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e3181e02f45","article-title":"Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers","volume":"34","author":"Thike","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21030","article-title":"Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma","volume":"103","author":"Grann","year":"2005","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-011-0211-9","article-title":"Clinicopathological features of triple-negative breast cancer in Taiwanese women","volume":"16","author":"Yao-Lung","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2018.11.012","article-title":"Postmastectomy radiation therapy for triple negative, node-negative breast cancer","volume":"132","author":"Haque","year":"2019","journal-title":"Radiotherapy Oncol J Eur Soc For Ther Radiol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2024.2333320","article-title":"Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives","volume":"24","author":"Kim","year":"2024","journal-title":"Expert Rev Anticancer Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001192","article-title":"Does bevacizumab carry a hope for metastatic triple-negative breast cancer in the era of immunotherapy","volume":"33","author":"Mohamed","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)33137-4","article-title":"Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37\u2008298 women with early breast cancer in 26 randomised trials","volume":"393","year":"2019","journal-title":"Lancet (London England)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx690","article-title":"Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial","volume":"29","author":"M\u00f6bus","year":"2018","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.49.6489","article-title":"Marital status and survival in patients with cancer","volume":"31","author":"Aizer","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.03.3472","article-title":"Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status","volume":"24","author":"Newman","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa148","article-title":"Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial","volume":"113","author":"Albain","year":"2021","journal-title":"J Natl Cancer Institute"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27120","article-title":"Racial and ethnic inequality in survival outcomes of women with triple negative breast cancer","volume":"14","author":"Makhani","year":"2022","journal-title":"Cureus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.epi-15-0243","article-title":"Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study","volume":"24","author":"Tao","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics","volume":"17","author":"McCart Reed","year":"2015","journal-title":"Breast Cancer Res BCR"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.33.4714","article-title":"Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy","volume":"29","author":"Abdulkarim","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1634\/theoncologist.2011-s1-79","article-title":"Coming of age: breast cancer in seniors","author":"Muss","year":"2010","journal-title":"Oncologist"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1874031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:23:51Z","timestamp":1783657431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1874031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":30,"alternative-id":["10.3389\/fonc.2026.1874031"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1874031","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1874031"}}